Embecta Acquires Owen Mumford Holdings for Up to £150 Million
March 27, 2026
Embecta entered into a definitive agreement to acquire Owen Mumford Holdings Limited for up to £150 million, consisting of £100 million upfront cash and up to £50 million in performance-based payments tied to net sales of the Aidaptus next-generation auto-injector platform. The deal was designed to accelerate embecta’s transformation into a broader medical supplies company with a differentiated drug-delivery platform for pharmaceutical partners and chronic care patients across obesity, diabetes, autoimmune diseases, and anaphylaxis.
- Buyers
- Embecta
- Targets
- Owen Mumford Holdings Limited
- Industry
- Healthcare Services
- Location
- Oxfordshire, United Kingdom
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction
December 9, 2025
Medical Devices
Montagu and Kohlberg have entered into a definitive agreement to acquire Teleflex Medical OEM from Teleflex Incorporated for $1.5 billion in a carve-out transaction. The business is expected to close in the second half of 2026, subject to regulatory approvals and other customary closing conditions, after which it will operate as an independent global contract developer and manufacturer.
-
Emmes Acquires Essex Management
March 21, 2023
Healthcare Services
Emmes, a global full-service clinical research organization, acquired Essex Management, a bioinformatics and health information technology consultancy, to enhance Emmes' data, bioinformatics and HIT capabilities. The acquisition adds more than 100 employees and expands Emmes' ability to serve government, academic and biopharma clients, including continued support for the National Cancer Institute.
-
Aztiq and Innobic Consortium Acquires Alvogen Emerging Markets Holdings for $500M
May 10, 2022
Pharmaceuticals
Aztiq Pharma Partners (led by Róbert Wessman) and Innobic (Asia) Company Limited, through Aztiq II HoldCo, completed a $500 million acquisition of 100% of Alvogen Emerging Markets Holdings Limited (AEMH). The deal makes the consortium the leading shareholder in Lotus Pharmaceuticals and the owner of Alvogen Malta Holding Ltd. (the shareholder of Adalvo), positioning the group to expand pharmaceutical capabilities and commercial reach—particularly across ASEAN markets.
-
Catalyst Clinical Research Acquires Aptus Clinical
May 4, 2022
Healthcare Services
Catalyst Clinical Research, a portfolio company of NovaQuest Capital Management, has acquired U.K.-based Aptus Clinical to accelerate Catalyst's European expansion and broaden its oncology and early-phase clinical services. The deal creates a multi-region CRO operating across North America and Europe, increases Catalyst's patient reach by nearly 600 and lifts combined headcount to more than 800.
-
Montagu Acquires Stake in Intech (Orthopaedic Medical Device Manufacturer)
July 12, 2021
Medical Devices
Montagu, a European private equity firm, has entered into and closed a strategic investment in Intech, the France-based global leader in contract manufacturing of orthopaedic surgical instruments. The transaction follows negotiations with existing investors Eurazeo PME and Andera Partners and will see Montagu support Intech’s management to accelerate organic and external growth, expand capacity, and strengthen its position in orthopaedics.
-
Prenetics / DNAFit Acquire Oxsed (Oxford University Spin-out)
October 28, 2020
Medical Devices
Hong Kong-based Prenetics, via its UK entity DNAFit Life Sciences Limited, has acquired Oxsed, an Oxford University spin-out that developed a rapid RT-LAMP COVID-19 testing platform. The acquisition gives DNAFit/Prenetics exclusive global rights to the Oxsed technology to accelerate R&D, scale manufacturing and deploy rapid point-of-care testing (including airport trials) worldwide.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.